Carcinoid tumors: What should increase our suspicion?

Cleveland Clinic Journal of Medicine

Volumn 75, Issue 12, 2008, Pages 849-855

  Aggarwal, Gaurav ^a   Obideen, Kamil ^a   Wehbi, Mohammad ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOID; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW;

CARCINOID TUMOR; HUMANS; PROGNOSIS;

EID: 59849129436     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.75a.08002     Document Type: Review

References (22)

1. Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumors. Lancet Oncol 2008; 9:61-72.
2. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 2005; 128:1717-1751.
3. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97:934-959.
4. DeVries H, Verschueren R, Willemse P, Kema I, DeVries E. Diagnostic, surgical, and medical aspect of midgut carcinoids. Cancer Treat Rev 2002; 28:11-25.
5. Robertson RG, Griger WJ, Davis NB. Carcinoid tumors. Am Fam Physician 2006; 74:429-434.
6. Horton KM, Kamel I, Hofman L, Fishman EK. Carcinoid tumors of the small bowel: a multitechnique imaging approach. AJR Am J Roentgenol 2004; 182:559-567.
7. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999; 340:858-868.
8. Bendelow J, Apps E, Jones LE, Poston GJ. Carcinoid syndrome. Eur J Surg Oncol 2008; 34:289-296.
9. Fink G, Krelbaum T, Yellin A, et al. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 2001; 119:1647-1651.
10. Bhattacharyya S, Toumpanakis C, Caplin ME, Davar J. Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century. Am J Cardiol 2008; 101:378-381.
11. Nasr C. Flushing: is it carcinoid or something else? Cleveland Clinic Disease Management Project, 2004. Available at http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/ endocrinology/flushing/flushing.htm. Accessed 10/25/08.
12. Modlin IM, Tang LH. Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today). Gastroenterology 1997; 112:583-590.
13. Campana D, Nori F, Piscitelli L, et al. Chromogranin A: is it a useful marker of neuroendocrine tumors? J Clin Oncol 2007; 25:1967-1973.
14. Eriksson B, Oberg K. Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumors. Acta Oncol 1991; 30:477-483.
15. National Comprehensive Cancer Network. Carcinoid tumors. http://www.nccn.org/professionals/physician_gls/PDF/neuroendocrine.pdf. Accessed 10/25/08.
16. Oberg K, Kvols L, Caplin M, et al. Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 2004; 15:966-973.
17. Welin SV, Janson ET, Sundin A, et al. High-dose treatment with long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours. Eur J Endocrinol 2004; 151:107-112.
18. Arnold R, Trautmann ME, Creutzfeldt W, et al. Somatostatin analogue octreotide and inhibition of tumor growth in metastatic endocrine gastroenteropancreatic tumors. Gut 1996; 38:430-438.
19. Bajetta E, Zilembo N, Di Bartolomeo M, et al. Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Medical Oncology Group. Cancer 1993; 72:3099-3105.
20. Faiss S, Pape UF, Bohmig M, et al. Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon-alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors - the International Lanreotide and Interferon Alfa Study Group. J Clin Oncol 2003; 21:2689-2696.
21. Helland SK, Prosch AM, Viste A. Carcinoid tumors in the gastrointestinal tract - a population-based study from Western Norway. Scand J Surg 2006; 95:158-161.
22. Habal N, Sims C, Bilchik AJ. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol 2000; 75:310-316.